NIH-funded research Career grant

Propagation of GVHD through CD4+ T-cell recognition of gut bacteria

Official title: Propagation of graft vs. host disease through CD4+ T-cell cognate recognition of gastrointestinal microbiota

Funded at Fred Hutchinson Cancer Center · NIH-11377412 · Data updated 2026-11-12

Researchers are studying how a patient’s immune cells recognize gut bacteria after stem cell transplant to better understand and manage graft-versus-host disease.

More Microbiota research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$162,432
NIH project number5K08HL167161-04
Project IDNIH-11377412 on NIH RePORTER

Who could benefit from this research

Could help

Patients undergoing hematopoietic stem cell transplantation who are at risk for GVHD may benefit from insights gained through this research.

Less likely to help

This program does not involve direct patient treatment or recruitment for a clinical trial during the training period.

What this research studies

This program trains a clinician-scientist over five years to study how T cells reconstitute after stem cell transplant and how their response to gut bacteria influences GVHD. It combines clinical insights with computational modeling to move beyond correlations and explore mechanisms. The work aims to translate mechanistic knowledge into strategies to reduce GVHD while preserving immune function. The training team includes experts in GVHD and T-cell modeling to build a unique skill set that supports independent physician-scientist work.

Why it matters

Potential benefit: If successful, the research could lead to new approaches to prevent or lessen GVHD by targeting T-cell responses to the gut microbiome.

How similar studies have gone: Previous work links the GI microbiome to GVHD but deeper mechanistic understanding and translational tools are still developing.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Yeh, Albert Chia-Chun — Fred Hutchinson Cancer Center
  • Study coordinator: Yeh, Albert Chia-Chun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.